AI-generated summary
The authors report a pilot study of eight patients with recalcitrant Riehl's melanosis who received 10 to 18 sessions of a combined treatment: low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid. Three patients were rated almost clear and five showed marked improvement, with no serious adverse events reported. The authors describe the approach as potentially viable, but the small sample size limits how far these findings can be generalized.
- Participants
- 8
- Who or what was studied
- Eight patients with recalcitrant Riehl's melanosis, described as Asian patients in the conclusion, who had previously failed other treatments
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract describes a small pilot study of eight patients with no control group reported, and it does not report statistical details beyond the stated significance.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Pilot study, Fluence, Melanin, GRADE, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.